Procyrion’s Aortix device could heighten heart pump competition


Pay attention to Procyrion over the next several months. CEO Benjamin Hertzog tells that the company plans on heading to the clinic with a device that could heighten competition among makers of cardiac assist devices.

The Houston-based startup plans to begin 1st-in-human trials of its Aortix catheter-based heart pump in the 1st half of 2016.

Read More